Abstract:Purpose of review: The optimal revascularization strategy for coronary artery disease depends on various factors, such as disease complexity, patient characteristics, and preferences. Including a heart team in complex cases is crucial to ensure optimal outcomes. Decision-making between percutaneous coronary intervention and coronary artery bypass grafting must consider each patient's clinical profile and coronary anatomy. While current practice guidelines offer some insight into the optimal revascularization approach for the various phenotypes of coronary artery disease, the evidence to support either strategy continues to evolve and grow. Given the large amount of contemporary data on revascularization, this review aims to comprehensively summarize the literature on coronary artery bypass grafting and percutaneous coronary intervention in patients across the spectrum of coronary artery disease phenotypes. Recent findings: Contemporary evidence suggests that for patients with triple vessel disease, coronary artery bypass grafting is preferred over percutaneous coronary intervention due to better long-term outcomes, including lower rates of death, myocardial infarction, and target vessel revascularization. Similarly, for patients with left main coronary artery disease, both percutaneous coronary intervention and coronary artery bypass grafting can be considered, as they have shown similar efficacy in terms of major adverse cardiac events, but there may be a slightly higher risk of death with percutaneous coronary intervention. For proximal left anterior descending artery disease, both percutaneous coronary intervention and coronary artery bypass grafting are viable options, but coronary artery bypass grafting has shown lower rates of repeat revascularization and better relief from angina. The Synergy Between PCI with Taxus and Cardiac Surgery score can help in decision-making by predicting the risk of adverse events and guiding the choice between percutaneous coronary intervention and coronary artery bypass grafting. European and American guidelines both agree with including a heart team that can develop and lay out individualized, optimal treatment options with respect for patient preferences. The debate between coronary artery bypass grafting versus percutaneous coronary intervention in multiple different scenarios will continue to develop as technology and techniques improve for both procedures. Risk factors, pre, peri, and post-procedural complications involved in both revascularization strategies will continue to be mitigated to optimize outcomes for those patients for which coronary artery bypass grafting or percutaneous coronary intervention provide ultimate benefit. Methods to avoid unnecessary revascularization continue to develop as well as percutaneous technology that may allow patients to avoid surgical intervention when possible. With such changes, revascularization guidelines for specific patient populations may change in the coming years, which can serve as a limitation of this time-dated review.

Coronary artery bypass grafting in patients with ventricular dysfunction

Understanding the role of coronary artery revascularization in patients with left ventricular dysfunction and multivessel disease

Coronary Revascularisation in Heart Failure with Reduced Ejection Fraction

Mid-Term Results of Coronary Bypass Graft Surgery in Patients with Ischaemic Left Ventricular Systolic Dysfunction and No Detected Myocardial Viability

The Prognostic Impact Of Heart Failure With Preserved Ejection Fraction In Patients Undergoing Coronary Artery Bypass Grafting

Past and present of cardiocirculatory assist devices: a comprehensive critical review.

Current Practice of State-of-the-Art Coronary Revascularization in Patients with Heart Failure

Effects Of Myocardial Viability And Left Ventricular Remodeling On Survival Of Patients With Heart Failure And Reduced Ejection Fraction After Coronary Artery Bypass Grafting

Revascularization and outcomes in ischaemic left ventricular dysfunction after heart failure admission: The RevascHeart study

Current Landscape and Future Directions of Coronary Revascularization in Ischemic Systolic Heart Failure: A Review

Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft among Patients with Coronary Artery Disease and Left Ventricular Systolic Dysfunction: a Meta-analysis

How Worthy Coronary Artery Bypass-Graft Surgery In Old Patients Is? Twenty Years Single Center Experience.

Role of Surgical Ventricular Restoration in the Treatment of Ischemic Cardiomyopathy.

A review of the conservative versus invasive management of ischemic heart failure with reduced ejection fraction

Effects of different surgical strategies and left ventricular remodelling on the outcomes of coronary artery bypass grafting in heart failure patients with reduced ejection fraction

Concepts and Misconceptions

[Myocardial viability: when and how to look for it, its prognostic impact and interaction with benefits of revascularization]

Clinical and functional outcomes associated with pulmonary complications after coronary artery bypass grafting

Heart Rate Variability and Coronary Artery Bypass Grafting: A Systematic Review

The Current State of Coronary Revascularization: Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Interventions

Impact of left ventricular ejection fraction on hospital and long term outcomes after coronary artery bypass graft surgery